Toublet FX

References (3)

Title : Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model - Travers-Lesage_2026_Eur.J.Med.Chem_307_118670
Author(s) : Travers-Lesage V , Crouzier L , Antonijevic M , Wang A , Toublet FX , Davis A , Modeste F , Brazzolotto X , Nachon F , Since M , Maurice T , Rochais C , Dallemagne P
Ref : Eur Journal of Medicinal Chemistry , 307 :118670 , 2026
Abstract :
PubMedSearch : Travers-Lesage_2026_Eur.J.Med.Chem_307_118670
PubMedID: 41702369

Title : Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT(6) receptor antagonist with therapeutic interest in Alzheimer's disease - Toublet_2021_Eur.J.Med.Chem_210_113059
Author(s) : Toublet FX , Lalut J , Hatat B , Lecoutey C , Davis A , Since M , Corvaisier S , Freret T , Sopkova-de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 210 :113059 , 2021
Abstract :
PubMedSearch : Toublet_2021_Eur.J.Med.Chem_210_113059
PubMedID: 33310288

Title : Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease - Toublet_2019_Molecules_24_
Author(s) : Toublet FX , Lecoutey C , Lalut J , Hatat B , Davis A , Since M , Corvaisier S , Freret T , Sopkova de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Molecules , 24 : , 2019
Abstract :
PubMedSearch : Toublet_2019_Molecules_24_
PubMedID: 31370232